Pharmacogenomic tests help physicians to prescribe the right medication for their patients with a personalized approach. This helps to improve clinical outcomes as well as provide financial value to the health system. There are many compelling studies that support significant cost-savings value from introducing pharmacogenomics to physicians and patients. This means significant reductions in the current month to year-long trial and error of process which is the nominal practice of medical professionals.
Statistics show that 60% of the Canadians are unhappy with their prescription medications due to various side effects. Considering that the same statistics have 41% Canadians currently on prescription medication and 25% on two or more and with Canada spending $35 billion on prescription medicines annually, pharmacogenomic tests have huge potential to significantly improve the prescription cycle through personalized precision.